Consistently, the group of mice treated with the DNA-PKcs inhibitor NU7441 and irradiation survived longer than those treated with NU7441 or irradiation alone (Figure 1g), indicating that the inhibition of DNA-PKcs can increase the efficacy of RT against GBs [67]. Here, PRKDC is linked to Guillain-Barre syndrome.